Taylor Farms, one of the largest fresh-cut produce suppliers in North America, contacted the Trump White House in an effort to delay a recall announcement tied to a major cyclospora outbreak, according to a Wall Street Journal report published July 25, 2026 (WSJ). The call came amid an escalating multi-state outbreak of cyclosporiasis — an intestinal illness caused by the cyclospora parasite — linked to iceberg lettuce from the company's Mexican subsidiary, Taylor Farms de Mexico, based in Guanajuato.

The outbreak has grown substantially since the CDC first flagged it. As of the CDC's July 24 media release, the case count had reached 1,947 across an expanded set of states (CDC). The CDC expanded its investigation to four additional states that same day, bringing the outbreak to at least nine states (FDA). These figures build on a broader cyclosporiasis season: since May 1, 2026, the CDC had received reports of 1,645 confirmed domestic cases, and was aware of more than 5,100 total cases as of July 2026 (CDC HAN).

Taylor Farms de Mexico announced a voluntary removal of its central Mexico-sourced iceberg lettuce on July 17, 2026 (FDA). The recall, listed under the corporate name Taylor Fresh Foods, covered product shipped to 27 states (AP). The recalled lettuce was sold at retail stores and served in food service settings (CDC). CDC epidemiologic and traceback data — the process of tracking contaminated food back through the supply chain to its source — identified the iceberg lettuce from Taylor Farms de Mexico as the contaminated source (CDC). Taco Bell lettuce sourced from Taylor Farms was among the food service channels linked to cyclosporiasis (WSJ).

Taylor Farms stated on its recall page that the company stopped receiving product from the implicated lot and suspended distribution of the affected items (Taylor Farms).

The FDA's laboratory findings have shifted over the course of the investigation. The agency initially reported that a sample of lettuce from Taylor Farms tested positive for cyclospora. On July 21, the FDA walked back that finding, stating its review showed the result was a false positive (WSJ). The Guardian had reported on July 20 that the FDA characterized the original test result as a false positive (The Guardian). Despite the retraction, the recall remains in place (WSJ).

In a statement published July 24, Taylor Farms said that according to the FDA, there were no confirmed positive sample results for cyclospora product testing as of that date (Taylor Farms). The CDC, however, continues to identify the outbreak as linked to iceberg lettuce from Taylor Farms de Mexico based on epidemiologic and traceback evidence, which does not depend on a confirmed positive laboratory sample from the product itself.

Three threads converge here: a foodborne illness outbreak affecting nearly 2,000 confirmed cases across at least nine states; a regulatory agency reversing a key laboratory finding mid-investigation; and a major food supplier calling the White House to delay a public recall announcement. Each is significant on its own. Their overlap raises questions about how food safety communication is managed when scientific certainty is still evolving and when commercial pressure is directed at the political apparatus rather than the regulatory one.

The FDA's false positive retraction is, on its face, a correction that should have narrowed the investigation. It did not. The CDC's epidemiologic and traceback data independently identified the same product, and the recall was maintained. Outbreak investigations are not single-test pass-or-fail scenarios; they are weight-of-evidence proceedings where epidemiology, supply chain traceback, and laboratory confirmation each play distinct roles. When one leg of that structure wobbles, the rest can still stand.

The broader context here is the decision by Taylor Farms to direct its request to the White House rather than to the FDA. Food recalls in the United States are typically voluntary actions coordinated through FDA channels, and the regulatory framework does not give political offices authority over recall timing. The Journal report does not detail the outcome of the call, but the act itself places a food safety process under political pressure from the executive branch, which operates outside the FDA's scientific and enforcement apparatus.

For food safety and supply chain professionals, the episode captures a familiar tension: the cost of a recall, measured in product destruction, retail withdrawals across 27 states, and brand exposure, is immediate and quantifiable, while the cost of delay, measured in additional illnesses, is distributed and harder to attribute. The system is designed to err on the side of public health. Whether it consistently does so when political pressure enters the equation is a question this episode puts into sharp relief.